These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 19678722)

  • 1. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
    Camm J
    Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation.
    Cheng JW
    Am J Health Syst Pharm; 2010 May; 67(9 Suppl 5):S26-34. PubMed ID: 20410533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
    Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
    Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of patients with atrial fibrillation and dronedarone's place in therapy.
    Cohen M; Boiangiu C
    Adv Ther; 2011 Dec; 28(12):1059-77. PubMed ID: 22170292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
    Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.